Understanding the various dosage forms of BPC-157 and TB-500 is essential for laboratory research. This page provides an educational overview of the different physical forms, concentration standards, and measurement methodologies used in peptide research settings. All information is presented for educational purposes only.
1. BPC-157 And TB-500 Lyophilized Powder Form
The most common dosage form for both BPC-157 and TB-500 in research settings is lyophilized (freeze-dried) powder. This form is produced through a process that removes water from the peptide solution under vacuum, resulting in a stable, dry product. Lyophilization preserves the peptide's structural integrity and extends shelf life significantly compared to liquid formulations.
In this form, peptides are typically supplied in amber glass vials with rubber stoppers. The lyophilized cake may appear as a white or off-white solid. Each vial is labeled with the net peptide content, which is commonly expressed in milligrams (mg). Standard research vials for BPC-157 typically contain 5 mg of peptide, while TB-500 vials often contain 2 mg, 5 mg, or 10 mg quantities.
2. BPC-157 And TB-500 Concentration Standards in Research
When researchers reconstitute lyophilized peptides, the resulting concentration depends on both the peptide mass and the volume of diluent used. Concentration is typically expressed in milligrams per milliliter (mg/mL). The following table illustrates common concentration calculations:
| Peptide Mass | Diluent Volume | Final Concentration | Molar Concentration (BPC-157) |
|---|---|---|---|
| 5 mg BPC-157 | 1 mL | 5 mg/mL | 3.52 mM |
| 5 mg BPC-157 | 2 mL | 2.5 mg/mL | 1.76 mM |
| 5 mg TB-500 | 1 mL | 5 mg/mL | 1.01 mM |
| 2 mg TB-500 | 1 mL | 2 mg/mL | 0.40 mM |
These calculations illustrate an important point: due to the difference in molecular weights between BPC-157 (~1,419.55 g/mol) and TB-500 (~4,963.55 g/mol), equivalent mass concentrations produce very different molar concentrations. Researchers must account for this when designing experiments. For more on this topic, see our dosing terminology page.
3. BPC-157 And TB-500 Reconstituted Solution Form
Once reconstituted, peptide solutions require specific handling. Bacteriostatic water (0.9% benzyl alcohol in sterile water) is the most commonly used diluent in research settings. The benzyl alcohol acts as a preservative, helping to prevent bacterial contamination of the reconstituted solution.
Reconstituted solutions should be stored at 2-8°C (refrigerated) and are generally considered stable for 30-60 days when properly handled. Freezing reconstituted peptide solutions is generally not recommended, as freeze-thaw cycles can lead to peptide degradation and aggregation.
4.BPC-157 And TB-500 Blend Dosage Forms
Some research suppliers offer BPC-157 and TB-500 in combined blend formulations. In these products, both peptides are present in the same vial as a lyophilized mixture. Blend dosage forms require additional considerations regarding the ratio of the two peptides. Common blend ratios include 1:1 (equal mass) and formulations where BPC-157 is present at a higher mass ratio due to its lower molecular weight.
For a detailed analysis of blend formulation chemistry, including ratio considerations and amino acid composition, visit our blend composition page.
5.BPC-157 And TB-500 Specialized Delivery Forms
In addition to standard vial formulations, BPC-157 and TB-500 are available in several specialized delivery forms for research applications:
- Nasal spray formulations – Pre-mixed solutions designed for intranasal delivery research. See our nasal spray formulation page for details.
- Pen delivery systems – Precision dosing devices that combine formulation and delivery mechanism. Our pen delivery page covers component design.
- Injectable preparations – Sterile solutions prepared for subcutaneous or intramuscular research. See our injection preparation page.
Accurate measurement of peptide content is critical in research. Peptide quantification is typically performed using UV spectrophotometry at 280 nm (for peptides containing aromatic residues) or amino acid analysis. Certificate of Analysis (CoA) documents should accompany all research-grade peptide products, verifying purity (typically >98% by HPLC) and peptide content.
6.BPC-157 And TB-500 Quality Documentation
Research-grade peptide dosage forms should be accompanied by comprehensive documentation. This includes the Certificate of Analysis (CoA), which verifies peptide identity (by mass spectrometry), purity (by HPLC), and net content. Additional documentation may include amino acid analysis results, endotoxin testing data, and stability reports. For information about research documentation standards, see our research protocol page.